Organon & Co.
OGNOrganon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
Drugs in Pipeline
71
Phase 3 Programs
54
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 1 past
No catalysts found.
How OGN's past catalysts played out
asenapine
Schizophrenia
Corifollitropin alfa
In Vitro Fertilization
Salmeterol xinafoate
Exercise Induced Asthma
MK0733 / Duration of Treatment: 18 Weeks
HDL Cholesterol
MK0954, /Duration of Treatment : 16 Weeks
Hypertension
EZ 10 mg/Atorva 20 mg FDC
Hypercholesterolemia
Mometasone Furoate/Formoterol Fumarate Combination MDI 100/10 mcg BID
Asthma
Eptifibatide (Integrilin)
Myocardial Ischemia
MK0462, rizatriptan benzoate / Duration of Treatment -1day
Migraine
Rescue medication
Bipolar Disorder
alendronate
Paget's Disease of Bone
Atorvastatin 10 mg
Hypercholesterolemia
Asenapine 5 mg
Schizophrenia
MK-0954A
Hypertension
ibandronate
Postmenopausal Osteoporosis
MK0954, /Duration of Treatment : 5 Years
Hypertension and Left Ventricular Hypertrophy (Thickening of the Main Pumping Chamber of the Heart)
MK0906, finasteride / Duration of Treatment: 48 weeks
Benign Prostatic Hyperplasia
SCH 900962 / Corifollitropin alfa / Org 36286
Infertility
MK0217A, alendronate sodium (+) cholecalciferol / Duration of Treatment: 15 weeks
Osteoporosis
Tibolone 2.5 mg
Postmenopausal Women
MK0663, Etoricoxib / Duration of Treatment : 12 Weeks
Recurrent Low Back Pain
A-Phase: tirofiban; Z-Phase simvastatin
Acute Coronary Syndrome
Radiopaque Implanon
Contraception
NOMAC-E2
Contraception
Desloratadine (Clarinex)
Allergic Rhinitis
tibolone
Sexual Dysfunction
Desloratadine 5 mg
Eczema
tapinarof cream, 1%
Plaque Psoriasis
phenylephrine
Rhinitis, Allergic, Seasonal
5-mg Desloratadine
Rhinitis, Allergic, Seasonal
MK0217, alendronate sodium / Duration of Treatment : 2 Years
Osteoporosis, Postmenopausal
Mometasone Furoate Nasal Spray (MFNS)
Nasal Polyps
Mometasone Furoate/Formoterol Fumarate (MF/F) 100/5 mcg MDI
Asthma
DRSP-EE
Contraception
Part I - etoricoxib 60 mg
Spondylitis, Ankylosing
Mometasone furoate/formoterol (MF/F) MDI
Asthma
Haloperidol
Schizophrenia
MK0663, etoricoxib
Rheumatoid Arthritis
FOSAVANCE 5600 (Alendronate Sodium (+) cholecalciferol)
Osteoporosis
Etoricoxib 90 mg
Pain, Postoperative
MK0217, /Duration of Treatment : 12 Months
Osteoporosis, Postmenopausal
desloratadine
Dermatitis, Atopic
MK0462, rizatriptan benzoate / Duration of Treatment: 1day
Migraine
Radiopaque Etonogestrel Implant
Contraception
rizatriptan benzoate
Migraine Headache
Tapinarof
Plaque Psoriasis
losartan potassium
Hypertension
mometasone furoate/formoterol fumarate combination MDI 200/10 mcg BID
Asthma
Asenapine - Open Label
Schizophrenia
Simvastatin 20 mg
Hypercholesterolemia
Rizatriptan 5 mg
Migraine Disorders
SCH No. 418131 (Mometasone Furoate/Formoterol Furoate abbreviated MF/F )
Asthma
mometasone furoate combination MDI 200/10 mcg BID
Asthma
MK0663, etoricoxib / Duration of Treatment: 6 Weeks
Osteoarthritis
Mometasone Furoate (MF) Metered Dose Inhaler (MDI), 25 mcg
Asthma
MK0663, etoricoxib / Duration of Treatment: Part I (6 weeks), Part II (8 weeks)
Osteoarthritis
Desloratadine 2.5 mg
Post-nasal Drip
MFNS
Acute Rhinosinusitis
Nomegestrol acetate (NOMAC)
Contraception
Nomegestrol acetate contraceptive vaginal ring (NOMAC-CVR)
Dysmenorrhea
Etoricoxib 75 mg 4% DMSO Gel
Osteoarthritis Pain
mometasone furoate/formoterol 100/10 mcg
Asthma
E6005
Atopic Dermatitis
Mometasone furoate
Rhinitis, Allergic, Perennial
OG-6219
Endometriosis
etoricoxib
Rheumatoid Arthritis
etonogestrel with testosterone undecanoate
Contraception
Org 36286
Infertility
Ganirelix
Controlled Ovarian Stimulation
E6005 ointment (vehicle)
Atopic Dermatitis
Org 36286 (corifollitropin alfa)
In Vitro Fertilization
Frequently asked questions
What is in Organon & Co.'s drug pipeline?→
CatalystAlert tracks 71 drug candidates in Organon & Co.'s (OGN) pipeline across Phase 3, Phase 2. Its lead program is asenapine (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Organon & Co.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Organon & Co. (OGN) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track OGN biotech catalysts?→
Add OGN to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Organon & Co.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.